Vermont could see vaccine for some as early as Dec. 10
Pfizer and its partner have said their vaccine candidate could be available to high-risk populations in the U.S. by the middle of December. Photo courtesy National Cancer Institute…
Pfizer and its partner have said their vaccine candidate could be available to high-risk populations in the U.S. by the middle of December. Photo courtesy National Cancer Institute…